Lexaria Bioscience Corp. - COM NEW (LEXX)

Historical Portfolio Holders from Q1 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
2.06M
Holdings value Q2 2024
$5.72M
Value change Q2 2024
+$3.24M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
28
Number of buys Q2 2024
14
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 2.06M $5.72M +$3.24M $2.78 28
2024 Q1 889K $3.23M -$348K $3.63 25
2023 Q4 1.2M $1.49M -$493K $1.25 19
2023 Q3 1.77M $1.77M +$883K $1.00 14
2023 Q2 892K $651K +$102K $0.73 12
2023 Q1 679K $1.85M -$42K $2.72 15
2022 Q4 696K $1.71M +$22.7K $2.46 15
2022 Q3 687K $1.68M +$290K $2.45 14
2022 Q2 561K $1.67M +$261K $2.98 15
2022 Q1 472K $1.41M +$54.7K $3.29 11
2021 Q4 457K $1.85M -$8.04K $4.04 10
2021 Q3 452K $2.83M +$206K $6.26 9
2021 Q2 417K $2.92M +$714K $7.00 8
2021 Q1 318K $1.78M +$1.78M $5.61 7